Januvia
Januvia is a prescription medicine containing sitagliptin, which belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by regulating insulin and glucagon levels in the body after eating, which helps to lower blood sugar levels in people with type 2 diabetes.
Dosage by Body Weight
The recommended adult dose is 100 mg taken orally once daily, with or without food. For patients with moderate, severe, or end-stage renal impairment, dosage adjustments are required (usually reduced to 50 mg or 25 mg once daily).
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy in pediatric patients under 18 years of age have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy in pediatric patients under 18 years of age have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy in pediatric patients under 18 years of age have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy in pediatric patients under 18 years of age have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and efficacy in pediatric patients under 18 years of age have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and efficacy in pediatric patients under 18 years of age have not been established. |
| 5-7 kg | Not recommended | N/A | Safety and efficacy in pediatric patients under 18 years of age have not been established. |
| 8-10 kg | Not recommended | N/A | Safety and efficacy in pediatric patients under 18 years of age have not been established. |
| 11-15 kg | Not recommended | N/A | Safety and efficacy in pediatric patients under 18 years of age have not been established. |
| 16-20 kg | Not recommended | N/A | Safety and efficacy in pediatric patients under 18 years of age have not been established. |
Formulation
Tablet
Purpose
Used to improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
Generic Name
SitagliptinScheduled Drug
Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.